These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10549571)

  • 1. Characterization of the NF-kappaB activation induced by TR8, an osteoclastogenic tumor necrosis factor receptor family member.
    Kim HH
    Arch Pharm Res; 1999 Oct; 22(5):454-8. PubMed ID: 10549571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
    Darnay BG; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1999 Mar; 274(12):7724-31. PubMed ID: 10075662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
    Galibert L; Tometsko ME; Anderson DM; Cosman D; Dougall WC
    J Biol Chem; 1998 Dec; 273(51):34120-7. PubMed ID: 9852070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.
    Darnay BG; Haridas V; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1998 Aug; 273(32):20551-5. PubMed ID: 9685412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6.
    Shin JN; Kim I; Lee JS; Koh GY; Lee ZH; Kim HH
    J Biol Chem; 2002 Mar; 277(10):8346-53. PubMed ID: 11751921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.
    Kim HH; Lee DE; Shin JN; Lee YS; Jeon YM; Chung CH; Ni J; Kwon BS; Lee ZH
    FEBS Lett; 1999 Jan; 443(3):297-302. PubMed ID: 10025951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC; Takada Y; Aggarwal BB
    J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis.
    Kobayashi N; Kadono Y; Naito A; Matsumoto K; Yamamoto T; Tanaka S; Inoue J
    EMBO J; 2001 Mar; 20(6):1271-80. PubMed ID: 11250893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation.
    Hong X; Xu L; Li X; Zhai Z; Shu H
    FEBS Lett; 2001 Jun; 499(1-2):133-6. PubMed ID: 11418127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.
    Ruocco MG; Maeda S; Park JM; Lawrence T; Hsu LC; Cao Y; Schett G; Wagner EF; Karin M
    J Exp Med; 2005 May; 201(10):1677-87. PubMed ID: 15897281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled RANK induces osteoclastogenesis ligand-independently.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
    Jimi E; Akiyama S; Tsurukai T; Okahashi N; Kobayashi K; Udagawa N; Nishihara T; Takahashi N; Suda T
    J Immunol; 1999 Jul; 163(1):434-42. PubMed ID: 10384146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6.
    Heyninck K; Beyaert R
    FEBS Lett; 1999 Jan; 442(2-3):147-50. PubMed ID: 9928991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
    Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
    Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
    J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.